Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00443599 · ClinicalTrials.gov registry record · NA

SPECS: Safe Pediatric Euglycemia in Cardiac Surgery

A NA study of Hyperglycemia and Heart Defects, Congenital, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
989
Enrollment target
2
Study locations

NCT00443599 is a NA study of Hyperglycemia and Heart Defects, Congenital that has completed, run by Boston Children's Hospital. The registered enrollment target is 989 participants, above the 853-participant average among 38 other Hyperglycemia trials with a reported enrollment target (16% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00443599, a NA study of Hyperglycemia and Heart Defects, Congenital, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
989 participants
Enrollment target
2
Study locations

Study Summary

Critically ill children, including children undergoing heart surgery, commonly develop elevated blood glucose (also known as "blood sugar") levels during their illness, which can lead to poor health outcomes and an increased risk of death. This study will examine the effectiveness of maintaining normal blood glucose levels at decreasing infections and improving recovery in young children undergoing heart surgery.

Interventions

  • OTHER Usual Care
  • DRUG Insulin

Study Locations (2)

Massachusetts

  • Children's Hospital Boston - Boston

Michigan

  • C.S. Mott Children's Hospital - Ann Arbor

Trial Details

FieldValue
Enrollment Target 989 participants
Start Date 2006-11
Est. Completion 2014-01
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00443599

The ClinicalTrials.gov registry entry for NCT00443599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 989 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 853-participant average among 38 other Hyperglycemia trials with a reported enrollment target (16% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hyperglycemia appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00443599 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT00443599 about?

NCT00443599 is a clinical study titled "SPECS: Safe Pediatric Euglycemia in Cardiac Surgery". Critically ill children, including children undergoing heart surgery, commonly develop elevated blood glucose (also known as "blood sugar") levels during their illness, which can lead to poor health outcomes and an increased risk of death. This study will examine the effectiveness of maintaining nor...

What is the current status of trial NCT00443599?

This trial is currently completed. It is a NA study. The enrollment target is 989 participants. The study started on 2006-11. Estimated completion is 2014-01.

What conditions does trial NCT00443599 study?

This clinical trial studies the following conditions: Hyperglycemia, Heart Defects, Congenital.

What interventions are being tested in trial NCT00443599?

The interventions under investigation include: Usual Care (OTHER), Insulin (DRUG).

Who is sponsoring clinical trial NCT00443599?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00443599 being conducted?

This trial has 2 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.